Finance

Lists
260660:KOSDAQ
Korea Arlico Pharm Co Ltd
â‚©2,345.00
0.00%
(0.00) 1D
Jul 24, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 260660...
Open
â‚©2,350
High
â‚©2,360
Low
â‚©2,270
Mkt. cap
35.94B
Avg. vol.
161.57K
Volume
20.78K
Dividend
3.20%
Quarterly dividend
â‚©19
Ex-dividend date
Dec 27, 2023
52-wk high
â‚©5,760
52-wk low
â‚©2,205
EPS
-â‚©108
Shares outstanding
15.33M
No. of employees
230
Open
â‚©2,350
High
â‚©2,360
Low
â‚©2,270
Mkt. cap
35.94B
Avg. vol.
161.57K
Volume
20.78K
Dividend
3.20%
Quarterly dividend
â‚©19
Ex-dividend date
Dec 27, 2023
52-wk high
â‚©5,760
52-wk low
â‚©2,205
EPS
-â‚©108
Shares outstanding
15.33M
No. of employees
230
News stories
From sources across the web
About Korea Arlico Pharm Co Ltd
CEO-
Employees230
Founded1992
Headquarters-
SectorPharmaceutical industry
Websitearlico.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
50.30B
52.20B
48.33B
48.32B
Cost of goods sold
23.57B
26.03B
23.53B
22.03B
Cost of revenue
23.57B
26.03B
23.53B
22.03B
Research and development expenses
924.91M
2.52B
654.07M
2.21B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.39B
23.16B
25.83B
24.81B
Operating expense
25.06B
26.17B
26.48B
28.05B
Total operating expenses
48.63B
52.20B
50.01B
50.08B
Operating income
1.66B
4.03M
-1.69B
-1.76B
Other non operating income
-1.06B
-360.93M
1.87B
966.39M
EBT including unusual items
604.71M
-356.90M
-1.79B
-795.59M
EBT excluding unusual items
604.71M
-356.90M
-1.82B
-795.59M
Income tax expense
71.96M
196.85M
-809.31M
-174.99M
Effective tax rate
11.90%
-55.15%
45.15%
22.00%
Other operating expenses
31.09M
77.76M
27.07M
107.82M
Net income
532.75M
-553.75M
-983.35M
-620.60M
Net profit margin
1.06%
-1.06%
-2.03%
-1.28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
230.21M
-
Interest expense
-
-
-2.16B
-
Net interest expenses
-
-
-1.93B
-
Depreciation and amortization charges
267.64M
262.11M
-261.66M
83.46M
EBITDA
2.38B
1.19B
-362.79M
-517.53M
Gain or loss from assets sale
134.68M
-69.74M
-6.26M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer